期刊文献+

鳖甲水煎液药物血清对肝星状细胞的作用 被引量:17

Turtle Carapace Decoction and Drug Containing Serum on Hepatic Stellate Cells
下载PDF
导出
摘要 目的:实验研究鳖甲水煎液药物血清对肝星状细胞的影响和作用机制。方法:双抗夹心ELISA法检测鳖甲水煎液药物血清对TGF-β1刺激的LX-1细胞胶原及调节因子表达的影响,MTS法检测鳖甲水煎液药物血清对TGF-β1刺激的LX-1细胞增殖的影响,Western blot检测鳖甲水煎液药物血清对TGF-β1刺激的LX-1细胞活化、胶原合成及细胞外基质等表达的影响。结果:鳖甲水煎液药物血清能明显抑制TGF-β1刺激的LX-1细胞的增殖;显著下调TGF-β1刺激的LX-1细胞Ⅰ、Ⅲ、Ⅳ型胶原、HA与α-SMA蛋白表达;并作用于TGF-β1下游信号通道蛋白,抑制Smad 3及P-smad3等因子表达,从而阻断TGF-β1等因子的生物学效应;能显著上调MMP 1、MMP 3蛋白表达,同时通过抑制TIMP-1蛋白表达、更有利于改善胶原酶活性,从而促进ECM的降解。在实验浓度范围内,鳖甲水煎液药物血清对肝星状细胞的作用呈现量效关系,作用显著优于目前有效的抗肝纤维化药物或细胞因子IFN-γ,与扶正化瘀胶囊作用相当。结论:鳖甲水煎液药物血清能抑制肝星状细胞活化增殖及细胞外基质合成分泌、促进细胞外基质降解吸收,调控细胞因子水平及信号传导通路,从而发挥抗肝纤维化的作用。本实验进一步验证了鳖甲抗肝纤维化药效学的有效性,为鳖甲抗肝纤维化的药效物质基础研究及其活性组分抗纤维化新药研发、保健品开发和临床医疗提供科学依据和研究思路。 Objective :To evaluate the Turtle Carapace Decoction and drug containing serum on hepatic stellate cells (HSC). Methods : Double - antibody sandwich ELISA assay was used to detect the effect of Turtle Carapace Decoction and drug containing serum on TGF- β1 -induced collagen and regulatory factors expression in LX -1 cells; MTS assay was used to detect the effect of Turtle Carapace Decoction and drug containing serum on TGF - β1 - induced LX - 1 cell pro- liferation ; Western blotting analysis was used to detect the effect of Turtle Carapace Decoction and drug containing serum on TGF -β1 - induced LX - 1 cell activation, collagen synthesis and extracellular matrix expression. Results:Turtle Cara- pace Decoction and drug containing serum can significantly inhibit HSC proliferation and down - regulate TGF - β1 - in- duced type Ⅰ, type Ⅲ and type Ⅳ collagen, α - SMA and HA expressions in LX - 1 cells, and for the TGF -β1 down- stream signal pathway proteins, it can inhibit the expressions of Smad 3, P - smad3 and other cytokines, which act on the TGF - β1 feedback loop in all stages of blocking TGF - β1. Moreover, Turtle Carapace Decoction and drug containing serum can significantly strengthen the expressions Of MMP - 1 and MMP - 3 proteins. By inhibiting TIMP - 1 protein ex- pression, it was conducive to improve collagen enzyme activity, and to promote ECM degradation. Within the experimen-tal concentrations, the effect of Turtle Carapace Decoction and drug containing serum on hepatic stellate cells was in a dose- dependent manner, and this effect was significantly better than those of γ - interferon, and was comparable to those of Fuzheng Huayu capsule, and generally accepted effective anti - liver fibrosis drugs or cytokine. Conclusion : Turtle Carapace Decoction and drug containing serum can inhibit hepatic stellate cells activated multiplication and extra cellular matrix (ECM) synthesis or secretion, promote ECM degradation, regulate cell factor level and regulate signaling path- way, and significantly block or treat liver fibrosis. This experimental result is verifying the validity of turtle carapace for anti - liver fibrosis, providing scientific evidences and research ideas for basic investigation on material basis for its anti - liver fibrosis effect as well as development and clinical application of its active components.
出处 《中华中医药学刊》 CAS 2013年第11期2524-2528,共5页 Chinese Archives of Traditional Chinese Medicine
基金 衢州市科技计划项目(20061103)
关键词 鳖甲 水煎液 药物血清 肝星状细胞 turtle carapace decoction drug containing serum hepatic stellate cells
  • 相关文献

参考文献9

  • 1Urtasun R, Nieto N. Hepatic stellate cells and oxidative stress [ J ]. Rev Esp Enferm Dig, 2007,99:223 - 230.
  • 2Wan M ,Tang Y ,Tytler EM ,et al. Smad4 protein stability is regu- lated by ubiquitin |igase SCF beta - TrCP1 [ J ]. Biol Chem, 2004,279 : 14484 - 14487.
  • 3L C(,, Kmlg HR, Homer RJ, et al. Trmlsgenic modeling of trans- tbrming growth factor - beta ( 1 ) : role of apoptosis in fibrosis and alveolar remodeling[ J ]. Am Thorac So ,2006,3:418 - 423.
  • 4Breitkopf K, Godoy P, Ciuclan L,et al. TGF - beta/Smad signa- ling ill tile injured liver[ J ]. Z Gastroentero1,2006 ,44 :57 -66.
  • 5Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF - beta signaling pathway in hepatic fibrosis [ J ]. Liver lnt, 2006,26 : 8 - 22.
  • 6Svegliati- Baroni G, Inagaki Y, Rincon -Sanchez AR, et al. Early sponse of alpha2 (1) collagen to acetaldehyde in human hepatic slellate cells is TGF- beta independent [ J]. Hepatology, 2005,42 : 343 - 352.
  • 7Kmpf J, Gressner AM, Negwer A. Effieacy of serum laminin nleasurement for diagnosis of fibrotic liver diseases [ J ]. Clin Chem, 1988, 34:2026-2030.
  • 8蔡卫民,黄建荣.肝纤维化研究若干新进展[J].中华临床感染病杂志,2008,1(5). 被引量:7
  • 9高建蓉,张赤志,邵志华,刘焱文,杨顺江,吴和珍,胡祖良,何再安,张洪球,张建超,许汉林,杨玲,朱清静,邓志凤,赵椿.鳖甲对肝星状细胞增殖影响的研究[J].实用医学杂志,2007,23(11):1618-1620. 被引量:38

二级参考文献33

  • 1Friedman S L.Molecular regulation of hepatic fibrosis,an integrated cellular response to tissue injury[J].J Boil Chem,2000,275 (4):2247-2250.
  • 2Fredman S L,Lalazar A,Wong L,et al.HSC-T6 cells,an immortalized rat hepatic stellate cell line[J].Hepatology,1997,26(4 Pt 2):338A.
  • 3Canbay A;Friedman S;Gores GJ.Apoptosis:the nexus of liver injury and fthrosis[J],2004(02).
  • 4Rockey DC.Antifibretic therapy in chronic liver disease[J],2005(02).
  • 5Gorrell MD.Liver fibrosis:the hepatocytes revisited[J],2007(05).
  • 6Zeisberg M;Yang C;Martino M.Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition[J],2007(32).
  • 7Li Z;Dranoff JA;Chan EP.Transforming growth factorbeta and substrate stiffness regulate portal flbroblast activation in cullure[J],2007(04).
  • 8Friedman SL;Maher JJ;Bissell DM.Mechanisms and therapy of hepatic fibrosis:report of the AASLD single topic basic research conference[J],2000(06).
  • 9Bissell DM;Friedman SL;Maher JJ.Connective tissue biology and hepatic fibrosis:report of a conference[J],1990(03).
  • 10Bergamini C;Sgarra C;Trerotoli P.Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins[J],2007(06).

共引文献42

同被引文献169

引证文献17

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部